RYTVELA
RYTVELA is a deriviative of the peptide antagonist of interleukin-1 receptor 1 (IL-1R1) d- (RYTVELA) (HY-P10353) that contains all L-amino acids[1].
Product Specifications
CAS Number
[1200829-06-6]
UNSPSC
12352209
Target
Drug Isomer
Related Pathways
Others
Field of Research
Others
Purity
98.89
Smiles
OC(C=C1)=CC=C1C[C@H](NC([C@@H](N)CCCNC(N)=N)=O)C(N[C@@H]([C@H](O)C)C(N[C@@H](C(C)C)C(N[C@@H](CCC(O)=O)C(N[C@@H](CC(C)C)C(N[C@@H](C)C(O)=O)=O)=O)=O)=O)=O
Molecular Formula
C38H62N10O12
Molecular Weight
850.96
References & Citations
[1]Christiane Quiniou, et al. Interleukin-1 and ischemic brain injury in the newborn: Development of a small molecule inhibitor of IL-1 receptor. Semin. Semin Perinatol. 2008 Oct;32 (5) :325-33.
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Scientific Category
Peptides
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6304393-01 0.2 mL
GRIK3, NT (GRIK3, GLUR7, Glutamate receptor, ionotropic kainate 3, Excitatory amino acid receptor 5, Glutamate receptor 7) (AP)
Ask
View Details 
MBS6304393-02 5x 0.2 mL
GRIK3, NT (GRIK3, GLUR7, Glutamate receptor, ionotropic kainate 3, Excitatory amino acid receptor 5, Glutamate receptor 7) (AP)
Ask
View Details